Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 39Neoplasms, Plasma Cell 13Lymphoma 12Neuroblastoma 10Leukemia, Myeloid, Acute 10Lymphoma, Large B-Cell, Diffuse 9Immunoglobulin Light-chain Amyloidosis 8Lymphoma, Non-Hodgkin 6Myelodysplastic Syndromes 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5Uveal Melanoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Melanoma 3Lymphoma, Mantle-Cell 3Leukemia 3Amyloidosis 3Neoplasm Metastasis 2Hodgkin Disease 2Ganglioneuroblastoma 2Venentoclax 1Smoldering Multiple Myeloma 1Sarcoma, Ewing 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms by Histologic Type 1

Interventions

Doxorubicin 310-propargyl-10-deazaaminopterin 3Vincristine 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Gemcitabine 2Drug Therapy 2Cyclophosphamide 2Alemtuzumab 2romidepsin 1cc-486 1belinostat 1Vitamin B 12 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Prednisone 1Practice Guidelines as Topic 1Melphalan 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Hematopoietic Stem Cell Mobilization 1Folic Acid 1Etoposide 1Cytarabine 1Cladribine 1Carmustine 1Busulfan 1Brentuximab Vedotin 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, T-Cell × Melphalan × Clear all
NCT05466318 2022-07-25

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Sichuan University

Phase 3 Unknown
306 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡